SEO URLwww.firestrike.ai/deals/curevac-biontech-acquisition-2026-3
acquisitionAnnounced · Jan 24, 2026biotechSource · CredibleArticle · Factual
BioNTech acquires CureVac
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$1.25B
Target
CureVac
Nasdaq: CVAC · Tuebingen, Baden-Wuerttemberg
Acquirer
BioNTech
Full Acquisition
Status
Pending
BioNTech agreed to acquire CureVac. Reported deal value: $1.25B. Status: Pending. Sector: biotech. Target headquarters context: Tuebingen, Baden-Wuerttemberg, Germany.
This page summarizes publicly available information about the transaction as of 2026-01-24. Figures and status may change as filings and press coverage update.
CureVac Exits Public Markets Following BioNTech Acquisition 24.01. 20 26
Deal timeline
Announced
Jan 24, 2026 · ad-hoc-news.de
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biotech with a reported deal value of $1.25B. Figures and status may change as sources update.
Sources: ad-hoc-news.de · Primary article · FireStrike proprietary index